Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Eli Lilly (NYSE: LLY)
    3. /

Eli Lilly (NYSE: LLY) Share Price and News

$825.91 $3.40 (0.4%) Tuesday, 1 April 2025 at 7:00:00 am Australian Eastern Daylight Time

Eli Lilly Chart and Price Data

Created with Highcharts 11.4.3Eli Lilly PriceZoom1M3M6MYTD1Y5Y10YALL→www.fool.com.au

About Eli Lilly

Last updated 01-04-2025, 07:00:00am AEDT
Current Price $825.91
Change $3.40 (0.4%)
Close Price $825.91
Open Price $808.98
Bid $822.04
Ask $825.90
Day Range $789.40 - $828.01
Year Range $711.40 - $972.53
Volume 3,737,004
Average Volume 3,606,486
Market Cap $779,730,432,400.00
Earnings Per Share $11.49

Eli Lilly (NYSE: LLY)
Latest News

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

ResMed share price plunges 13% as weight-loss results reawaken worries

| James Mickleboro

Why are investors heading to the exits today? Let's see what's happening.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Evolution Mining, Karoon Energy, ResMed, and Sayona Mining shares are dropping today

| James Mickleboro

These ASX shares are having a tough session. But why?

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is the ResMed share price diving 5% today?

| James Mickleboro

Weight loss wonder drugs are weighing heavily on this stock.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

Goldman Sachs says this US stock is replacing Tesla in the Magnificent Seven

| Bronwyn Allen

And no, it's not a tech company. It's in the healthcare sector.

Read more »

medical asx share price represented by doctor giving thumbs up
ETFs

'Beyond our expectations': How to invest in obesity drugs like Ozempic with ASX ETFs

| James Mickleboro

This could be your way to invest in obesity drugs.

Read more »

Profile

since

Note